Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety
Severe Acute Respiratory Syndrom-CoronaVirus-2 (SARS-CoV-2) has spread worldwide since late 2019, causing coronavirus disease 19 (COVID-19) in humans, involving severe acute respiratory syndrome associated with a multi-symptom presentation. From Wuhan in the Hubei province of China [1,2], the virus spread rapidly in all continents, leading the World Health Organization, on March 11, 2020, to upgrade it as a pandemic [3]. There are currently so far nor approved preventive neither curative treatments.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Florian Slimano, Amandine Baudouin, J érémie Zerbit, Anne Toulemonde-Deldicque, Audrey Thomas-Schoemann, Régine Chevrier, Mikaël Daouphars, Isabelle Madelaine, Bertrand Pourroy, Jean-François Tournamille, Alain Astier, Florence Ranchon, Jean-Louis Ca Tags: Hot Topic Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Coronavirus | COVID-19 | International Medicine & Public Health | Pandemics | Respiratory Medicine | SARS | WHO